Market News / Story
ProMIS Neurosciences Inc. (PMN) Appoints Ivana Rubino as Chief Commercial Officer
·
ProMIS Neurosciences appointed Ivana Rubino, Ph.D., as Chief Commercial Officer, effective Oct. 5, 2026, and granted her a stock option for 80,000 shares at $9.37 under its 2026 Inducement Plan. Material Details #DetailAI Analyst View1Appoints Ivana Rubino as CCOC-level hire with AD launch experience may de-risk PMN310 commercialization path.280,000 options at $9.37 grantedEquity inducement aligns incentives; modest dilution but signals long-term focus.3CCO start date…